复锐医疗科技（01696）于2026年10月23日发布公告，称公司当日于香港联交所场内回购普通股10万股，占回购前已发行股本约0.021%。每股回购价介乎每股港币1.81元至1.875元，合计耗资约18.51万港元。
本次回购完成后，公司已发行股本仍为468,343,092股，其中467,644,692股为已发行股份（不包括库藏股份），库存股份则增至698,400股。该回购依据公司董事会于2026年6月24日获股东大会授予的回购授权进行，允许回购的股份总数为46,834,309股，截至本次回购累计已回购数量为698,400股，占授权时公司已发行股本0.149%。
公司指出，此次回购行为已严格遵守香港联合交易所有限公司证券上市规则及相关法律规定。公告由公司秘书方前厉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.